Cancer Biotherapy and Radiopharmaceuticals This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Short-Term Biological Toxicity Prediction of [177Lu]Lutetium-Oxodotreotide: An Original Retrospective Analysis
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - April 24, 2024 Category: Cancer & Oncology Authors: Julien Dubois Guillaume Tosato Philippe Garrigue David Taieb Benjamin Guillet Vincent Nail Source Type: research

LncRNA EBLN3P Accelerates Cell Proliferation and Invasion of Colon Cancer through Modulating the miR-519d-3p/ZFP91 Axis
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - April 10, 2024 Category: Cancer & Oncology Authors: Xiaohui Wang Yinzi Yue Jinhua Tan Fei Kou Bude Su Jin Xie Shuai Yan Source Type: research

Exosome-Derived MicroRNA-221-3p Desensitizes Breast Cancer Cells to Adriamycin by Regulating PIK3r1-Mediated Glycose Metabolism
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - March 26, 2024 Category: Cancer & Oncology Authors: Xiaolu Hong Xiaoping Pan Source Type: research

Pyrotinib and Trastuzumab Plus Chemotherapy Serve as an Acceptable Neoadjuvant Regimen Exhibiting Good Efficacy and Tolerance in HER2-Positive Breast Cancer Patients
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - March 25, 2024 Category: Cancer & Oncology Authors: Yibo Chen Tianyi Zhang Rui Zhang Xuchen Cao Source Type: research

Evaluation of 5 ′-tRF-His-GTG As a Molecular Biomarker in Breast Cancer Diagnoses and Prognosis
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - March 25, 2024 Category: Cancer & Oncology Authors: Xun Tang Jun Wu Yan Chen Daojuan Wang Tingyu Wang Yajing Weng Zhengquan Zhu Rui Peng Yong Wang Feng Yan Source Type: research

The Survival Benefit of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in the Management of Breast Cancer
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - March 21, 2024 Category: Cancer & Oncology Authors: Ruoyang Li Xuewei Zhao Yunfei Huang Chunxiao Li Lei Liu Meiqi Wang Jiaxing Wang Zhenchuan Song Source Type: research

Prognostic Signature in Osteosarcoma Based on Amino Acid Metabolism-Associated Genes
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - March 21, 2024 Category: Cancer & Oncology Authors: Liwen Feng Yuting Chen Xiangping Mei Lei Wang Wenjing Zhao Jiannan Yao Source Type: research

Participation of Long Noncoding RNA FOXP4-AS1 in the Development and Progression of Endometrioid Carcinoma with Epigenetically Silencing DUSP5
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - March 20, 2024 Category: Cancer & Oncology Authors: Leilei Liu Jingyun Zhao Hui Guo Jingde Jia Li Shi Jing Ma Zhengmao Zhang Source Type: research

Re: “Evaluating the Diagnostic Efficacy of 99mTc-Methionine Single-Photon Emission Computed Tomography–Computed Tomography: A Head-to-Head Comparison with 11C-Methionine Positron Emission Tomography–Magnetic Resonance Imaging in Glioma Patients” by Kumar et al.
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - March 14, 2024 Category: Cancer & Oncology Authors: Luca Filippi Source Type: research

The Role of [18F]FDG PET/CT in the Characterization of Thymic Epithelial Tumors at Initial Stage
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - March 14, 2024 Category: Cancer & Oncology Authors: Caner Civan Zeynep Gozde Ozkan Berker Ozkan Emine Goknur Isik Eren Erdogdu Duygu Has Simsek Salih Duman Yasemin Sanli Murat Kara Serkan Kuyumcu Alper Toker Source Type: research

Assessment of DNA/RNA Deregulation in Cancer Using 99mTc-Labeled Thiopurine
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - March 8, 2024 Category: Cancer & Oncology Authors: Chuang-Hsin Chiu David J. Yang Yi-Chen Liou Wei-Chung Chang Tsung-Hsun Yu Min-Ching Chung Yen-Chun Lee Ing-Jou Chen Pao-Yeh Wang Ching-Po Lin Hey-Jen Tsay Skye Hsin-Hsien Yeh Source Type: research

Acknowledgment of Reviewers 2023
Cancer Biotherapy and Radiopharmaceuticals,Volume 39, Issue 1, Page 103-103, February 2024. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - February 13, 2024 Category: Cancer & Oncology Source Type: research

Evaluation of 177Lu-Labeled Pertuzumab F(ab ′)2 Fragments for HER2-Positive Cancer Targeting: A Comparative In Vitro and In Vivo Study
Cancer Biotherapy and Radiopharmaceuticals,Volume 39, Issue 1, Page 64-74, February 2024. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - February 13, 2024 Category: Cancer & Oncology Authors: Rohit Sharma Archana Mukherjee Anuj Kumar Haladhar Dev Sarma Source Type: research

Synthesis, Quality Control, and Bench-to-Bed Translation of a New [68Ga]Ga-Labeled NOTA-Conjugated Bisphosphonate for Imaging Skeletal Metastases by Positron Emission Tomography
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - February 9, 2024 Category: Cancer & Oncology Authors: Sudipta Chakraborty Sucheta Chatterjee Rubel Chakravarty Haldhar D. Sarma Raviteja Nanabala Dibakar Goswami Ajith Joy Maroor Raghavan Ambikalamajan Pillai Source Type: research

Call for Special Issue Papers: Advances in Molecular Medicine
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - February 8, 2024 Category: Cancer & Oncology Authors: Maulin P. Shah Source Type: research